Proposed LDT Rule Raises Many Questions but Provides Few Answers
FDA Law Blog
OCTOBER 6, 2023
The amended regulation would read as follows (revisions underlined): In vitro diagnostic products are those reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae.
64 
Let's personalize your content